Experience

Kiniksa Pharmaceuticals

• United States
• Biotechnology Research
• 100 - 200 Employee

• SVP, Chief Commercial Officer

  • Jan 2022 - Present

• Group Vice President & General Manager (worldwide)

  • Jul 2020 - Jan 2022

  Responsibility for global franchise strategy and operations across all functional areas within rare/orphan cardiovascular disease.

• Vice President, European Operations

  • Jun 2019 - Jul 2020

  Head of European Operations of a biopharmaceutical company focused on discovering, acquiring, developing and commercialising therapeutic medicines for patients suffering from debilitating diseases with significant unmet need.



The AADC Research Trust

• United Kingdom
• Research Services
• 1 - 100 Employee

• Advisor to the Board of Trustees of The AADC Research Trust (Voluntary Role)

  • May 2019 - Present

  Voluntary role supporting the Board of Trustees of the charity. The AADC Trust are the only international advocacy group representing the incredible AADC community. This ultra rare, genetic, 'parkinsonism' disorder is caused by an enzyme deficiency. There are approximately 150-200 known suffers of AADC deficiency worldwide. The AADC Trust is dedicated to improving the lives of AADC patients around the globe. Voluntary role supporting the Board of Trustees of the charity. The AADC Trust are the only international advocacy group representing the incredible AADC community. This ultra rare, genetic, 'parkinsonism' disorder is caused by an enzyme deficiency. There are approximately 150-200 known suffers of AADC deficiency worldwide. The AADC Trust is dedicated to improving the lives of AADC patients around the globe.



Novartis Gene Therapies

• United States
• Biotechnology Research
• 700 & Above Employee

• Vice President, Marketing, Diagnostics & Training - EMEA

  • May 2018 - Jun 2019

  Leading on all strategic elements of product launch including marketing, diagnostics, patient identification and Newborn Screening initiatives across the Europe, Middle East & Africa region. Leading on all strategic elements of product launch including marketing, diagnostics, patient identification and Newborn Screening initiatives across the Europe, Middle East & Africa region.



Spark Therapeutics, Inc.

• United States
• Biotechnology
• 700 & Above Employee

• Senior Director, Genetic Diagnostic Strategy - Europe

  • Jul 2017 - May 2018

  Preparing for the commercialisation of the first-in-class gene therapy for a rare genetic disease Building a European field-facing operation pre-launch in sequential launch markets Leading on disease awareness and patient identification to prepare the market landscape for launch Patient identification and joint working with physician and laboratory KOLs across Europe to advance disease understanding and management Preparing for the commercialisation of the first-in-class gene therapy for a rare genetic disease Building a European field-facing operation pre-launch in sequential launch markets Leading on disease awareness and patient identification to prepare the market landscape for launch Patient identification and joint working with physician and laboratory KOLs across Europe to advance disease understanding and management



Alexion Pharmaceuticals, Inc.

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Director, Commercial & Marketing Lead - EMEA

  • Sep 2015 - Aug 2017

  Built and led strategic and operational commercial plans for the successful international launch of an Orphan drug Executed key market readiness activities including country launch planning, educational programs, promotional activities and market research and insights Responsibility for EMEA operational budget Built and led strategic and operational commercial plans for the successful international launch of an Orphan drug Executed key market readiness activities including country launch planning, educational programs, promotional activities and market research and insights Responsibility for EMEA operational budget



Synageva BioPharma Corp.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Country General Manager - UK and Ireland

  • Apr 2014 - Aug 2015

  Responsibility for building the UK & Ireland infrastructure and preparing for launch of the organisation's first drug, an Enzyme Replacement Therapy for an ultra-orphan disease within Lysosomal Storage Disorders Full general manager responsibilities including cross-functional team build Market access planning for all 5 nations including NICE, NCPE, AWMSG and SMC Responsibility for Key Opinion Leader development,, payer engagement, advisory boards, government affairs and all aspects of launch planning



Kyowa Kirin International plc.

• United Kingdom
• Pharmaceutical Manufacturing
• 400 - 500 Employee

• National Sales Manager - UK

  • Jan 2013 - Apr 2014

  Leading distinct business units across mainstream and specialty medicine with responsibility of more then 100 personnel in the UKLeading sales growth across a portfolio of drugs in: Palliative Care, Oncology, Urology, Endocrinology, Osteoporosis, Pain Management, Colorectal, Anaesthetics, Gastroenterology and Elderly Care Multiple successful UK drug launches and line extensions

• Regional Business Manager, Specialist Care Team - South UK

  • Jan 2010 - Jan 2013

• Regional Business Manager, GP/Hospital team - SE England

  • 2008 - 2010

  First line management leading a team of 10 representatives (primary & secondary care)

• Heathcare Development Manager - SE England

  • 2006 - 2008

  Covering PCTs and PBC clusters in SE England:PCT projects, Formualry inclusions, PBC projects.

• GP/Hospital Representative - Kent

  • 2003 - 2006

  Covering GPs and Hospitals in Kent promoting various products including new drug launches and gaining PCT and Hospital formulary inclusions